Table 1 Demographic and clinical characteristics of the patients

From: Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial

Characteristic

Placebo (n = 31)

Low-dose IL-2 (n = 32)

Median age (range), years

55 (39–75)

56.5 (34–73)

Sex, no. (%)

 Female

7 (23)

3 (9)

 Male

24 (77)

29 (91)

BMI, kg m−2 (mean ± s.d.)

29.6 ± 5.8

29.8 ± 5.7

Ethnicity, no. (%)

 White

30 (97)

27 (84)

 Asian

1 (3)

3 (9)

 Black

0 (0)

0 (0)

 Mixed

0 (0)

1 (3)

 Other

0 (0)

1 (3)

Diagnosis at admission, no. (%)

 Unstable angina

0 (0)

2 (6)

 NSTEMI

15 (48)

11(34)

 STEMI

16 (52)

19 (59)

Median hsCRP level, mg l−1 (interquartile range)

10.1 (5.0–29.1)

8.4 (4.4–19.2)

Median high-sensitivity troponin I at the first dosing visit (interquartile range), ng l−1 (range) (reference range 0–54 ng l−1)

59 (20–346)

67 (28–305)

Median low-density lipoprotein–cholesterol level, mmol l−1 (interquartile range)

1.8 (1.40–2.70)

2.10 (1.68–2.40)

GRACE score at admission, mean ± s.d.

96.1 ± 19

95.4 ± 25

Cardiovascular history, no. (%)

 Hypertension

29 (94)

32 (100)

 Hypercholesterolemia

29 (94)

32 (100)

 Previous angioplasty

2 (6)

5 (16)

 Stroke

0 (0)

2 (6)

 Type 2 diabetes

0 (0)

2 (6)

Medication history, no. (%)

 Aspirin

31 (100)

32 (100)

 Clopidogrel or ticagrelor

31 (100)

32 (100)

 Statin

31 (100)

31 (97)

 β-Blocker

30 (97)

28 (88)

 Renin–angiotensin inhibitor

30 (97)

29 (91)

Smoking status, no. (%)

 Never smoked

12 (39)

12 (38)

 Current smoker

12 (39)

10 (31)

 Previous smoker

7 (22)

10 (31)

Baseline arterial inflammation, mean TBRmax

2.39 ± 0.28

2.26 ± 0.27

Treatment given for index ACS admission, no. (%)

 Percutaneous coronary angioplasty

31 (100)

30 (94)

 Medical management

0 (0)

2 (6)

Culprit vessel leading to index ACS admission, no. of patients (%)

 Left anterior descending artery

16 (52)

17 (53)

 Left circumflex artery

6 (19)

6 (19)

 Right coronary artery

9 (29)

9 (28)

  1. No. (%) is the number of participants (percentage of participants).
  2. GRACE, global registry of acute coronary events.